Greenwich LifeSciences, Inc. (GLSI)
18.38
-0.21
(-1.13%)
USD |
NASDAQ |
Sep 29, 16:00
18.50
+0.12
(+0.65%)
After-Hours: 20:00
Greenwich LifeSciences Price to Book Value : 86.56 for Sept. 29, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 86.56 |
| September 28, 2026 | 87.54 |
| September 25, 2026 | 85.80 |
| September 24, 2026 | 85.24 |
| September 23, 2026 | 82.46 |
| September 22, 2026 | 91.74 |
| September 21, 2026 | 87.57 |
| September 18, 2026 | 89.43 |
| September 17, 2026 | 86.60 |
| September 16, 2026 | 73.61 |
| September 15, 2026 | 75.77 |
| September 14, 2026 | 75.58 |
| September 11, 2026 | 72.76 |
| September 10, 2026 | 70.92 |
| September 09, 2026 | 70.78 |
| September 08, 2026 | 74.88 |
| September 04, 2026 | 75.11 |
| September 03, 2026 | 73.61 |
| September 02, 2026 | 74.12 |
| September 01, 2026 | 70.69 |
| August 31, 2026 | 70.40 |
| August 28, 2026 | 73.79 |
| August 27, 2026 | 88.20 |
| August 26, 2026 | 85.85 |
| August 25, 2026 | 87.54 |
| Date | Value |
|---|---|
| August 24, 2026 | 82.79 |
| August 21, 2026 | 78.50 |
| August 20, 2026 | 72.10 |
| August 19, 2026 | 81.66 |
| August 18, 2026 | 81.28 |
| August 17, 2026 | 81.85 |
| August 14, 2026 | 79.12 |
| August 13, 2026 | 77.14 |
| August 12, 2026 | 79.68 |
| August 11, 2026 | 73.23 |
| August 10, 2026 | 72.99 |
| August 07, 2026 | 67.62 |
| August 06, 2026 | 67.06 |
| August 05, 2026 | 67.77 |
| August 04, 2026 | 67.58 |
| August 03, 2026 | 63.76 |
| July 31, 2026 | 63.57 |
| July 30, 2026 | 66.02 |
| July 29, 2026 | 60.28 |
| July 28, 2026 | 63.34 |
| July 27, 2026 | 63.29 |
| July 24, 2026 | 61.13 |
| July 23, 2026 | 62.11 |
| July 22, 2026 | 62.49 |
| July 21, 2026 | 68.99 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.59 |
| Anika Therapeutics, Inc. | 1.944 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.487 |
Price to Book Value Related Metrics
| PEG Ratio | -0.7385 |
| Price | 18.38 |
| Earnings Yield | -8.25% |
| Market Cap | 269.79M |
| PEGY Ratio | -0.7385 |